Evidence map›Paper›PMID 39648213›Full record

ArticleGlobal health research and policy2024

Cost of TB care and equity in distribution of catastrophic TB care costs across income quintiles in India.

Kathiresan Jeyashree, Jeromie W V Thangaraj, Devika Shanmugasundaram, Sri Lakshmi Priya Giridharan, Sumit Pandey, Prema Shanmugasundaram, Sabarinathan Ramasamy, Venkateshprabhu Janagaraj, Sivavallinathan Arunachalam, Rahul Sharma and 9 more

Abstract read
In one paragraph

Article in Global health research and policy, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Kathiresan JeyashreeICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India. jshreek@gmail.com.ORCID http://orcid.org/0000-0001-6459-3659
Jeromie W V ThangarajICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Devika ShanmugasundaramICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Sri Lakshmi Priya GiridharanICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Sumit PandeyICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Prema ShanmugasundaramICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Sabarinathan RamasamyICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Venkateshprabhu JanagarajICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Sivavallinathan ArunachalamTB Support Network, WHO Country Office for India, New Delhi, India.
Rahul SharmaTB Support Network, WHO Country Office for India, New Delhi, India.
Vaibhav ShahTB Support Network, WHO Country Office for India, New Delhi, India.
Bhavani Shankara BagepallyICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Joshua ChadwickICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Hemant Deepak ShewadeICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.
Aniket ChowdhuryTB Support Network, WHO Country Office for India, New Delhi, India.
Swati IyerTB Support Network, WHO Country Office for India, New Delhi, India.
Raghuram RaoCentral TB Division, New Delhi, India.
Sanjay K MattooCentral TB Division, New Delhi, India.
Manoj V MurhekarICMR-National Institute of Epidemiology (ICMR-NIE), R-127, TNHB, Ayapakkam, Chennai, Tamil Nadu, 600077, India.

Funding

United States Agency for International Development 0011-0549-1023World Health Organization 001
6 · The paper itself

Abstract

backgroundTuberculosis (TB) poses a significant social and economic burden to households of persons with TB (PwTB). Despite free diagnosis and care under the National TB Elimination Programme (NTEP), individuals often experience significant out-of-pocket expenditure and lost productivity, causing financial catastrophe. We estimated the costs incurred by the PwTB during TB care and identified the factors associated with the costs.

methodsIn our cross-sectional study, we used multi-stage sampling to select PwTB notified under the NTEP, whose treatment outcome was declared between May 2022 and February 2023. Total patient costs were measured through direct medical, non-medical and indirect costs. Catastrophic costs were defined as expenditure on TB care > 20% of the annual household income. We determined the factors influencing the total cost of TB care using median regression. We plotted concentration curves to depict the equity in distribution of catastrophic costs across income quintiles. We used a cluster-adjusted, generalized model to determine the factors associated with catastrophic costs.

resultsThe mean (SD) age of the 1407 PwTB interviewed was 40.8 (16.8) years. Among them, 865 (61.5%) were male, and 786 (55.9%) were economically active. Thirty-four (2.4%) had Drug Resistant TB (DRTB), and 258 (18.3%) had been hospitalized for TB. The median (Interquartile range [IQR] and 95% confidence interval [CI]) of total costs of TB care was US$386.1 (130.8, 876.9). Direct costs accounted for 34% of the total costs, with a median of US$78.4 (43.3, 153.6), while indirect costs had a median of US$279.8 (18.9,699.4). PwTB < 60 years of age (US$446.1; 370.4, 521.8), without health insurance (US$464.2; 386.7, 541.6), and those hospitalized(US$900.4; 700.2, 1100.6) for TB experienced higher median costs. Catastrophic costs, experienced by 45% of PwTB, followed a pro-poor distribution. Hospitalized PwTB (adjusted prevalence ratio [aPR] = 1.9; 1.6, 2.2) and those notified from the private sector (aPR = 1.4; 1.1, 1.8) were more likely to incur catastrophic costs.

conclusionsPwTB in India incur high costs mainly due to lost productivity and hospitalization. Nearly half of them experience catastrophic costs, especially those from poorer economic quintiles. Enabling early notification of TB, expanding the coverage of health insurance schemes to include PwTB, and implementing TB sensitive strategies to address social determinants of TB may significantly reduce catastrophic costs incurred by PwTB.

Indexed as

TuberculosisAdultCost of IllnessCross-Sectional StudiesFemaleHealth Care CostsHealth ExpendituresHumansIncomeIndiaMaleMiddle AgedYoung AdultCatastrophic costsCosts of TB careDirect costsIndiaIndirect costs

Identifiers

PMID39648213
PMCPMC11626761

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.